Skip to content

MD Pharma

Active
Kortrijksesteenweg 1091 ·9051 Gent, Belgium
KBO/BCE: BE 0667.779.672
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age9 yrs
Connections9
Real estate1 parcel · 1.1 ha

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MD Pharma is 0.7% (low). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Trust signals

2 signals
More than 3 years active
Founded in 2016, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.7% Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate sector +Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 8 filing(s) on record for this company, latest fiscal year 2024 (verkort). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 verkort 30-07-2025 2025-00344169
31-12-2023 verkort 25-07-2024 2024-00289883
31-12-2022 verkort 31-08-2023 2023-00428277
31-12-2021 verkort 20-07-2022 2022-20218871
31-12-2020 verkort 04-06-2021 2021-17900294
31-12-2019 verkort 25-08-2020 2020-44700186
31-12-2018 verkort 30-08-2019 2019-59700062
31-12-2017 verkort 28-08-2018 2018-52200177

Directors

Directors & mandates

2 directors
Historic, not recently confirmed (2)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Aquitania BVBALegal entity
    Director· perm. rep.: Anja Imschoot
    State Gazette act 19063001 (09-05-2019)
    Not recently confirmed
    last confirmed in an act from 2019
  • MD CONSULTLegal entity
    Director· perm. rep.: Mario Debel
    State Gazette act 17059563 (26-04-2017)
    Not recently confirmed
    last confirmed in an act from 2017
    2 events
    • 01-04-2017 Appointed· Director
    • 01-04-2017 Appointed· Managing director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Statutory auditor

1 auditor
Statutory auditor IRE/IBR number Tenure
PwC Bedrijfsrevisoren CVBA
Company auditor · represented by Peter Opsomer
 - 22-11-2018 → 21-12-2018
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht(77400)
Legal form Public limited company(014)
Incorporation16-12-2016
StatusActive
Postal code9051

Structure & network

Connections & network

9 connected companies
MD CONSULT, Parent company MCMD CONSULTCeres Pharma, Shared corporate director CPCeres PharmaGLOBIFER INTL, Shared corporate director GIGLOBIFER INTL2PHARMA, Shared address 22PHARMA2PHARMA HOLDING, Shared address 2H2PHARMAHOLDINGb+pharma Belgium, Shared address BBb+pharmaBelgiumCeres Invest, Shared address CICeres InvestCeres Pharmaceuticals, Shared address CPCeresPharmace…icalsWhat's Cooking Group, Shared address WCWhat's CookingGroupMD Pharma MD Pharma0667.779.672
Group structureShared directorsShared address / shareholder
Group structure
MD CONSULT
Parent · 3 subsidiaries · 1 location
Control→
Network connections
Ceres Pharma
Shared corporate director
→
GLOBIFER INTL
Shared corporate director
→
2PHARMA
Shared address
→
2PHARMA HOLDING
Shared address
→
b+pharma Belgium
Shared address
→
Ceres Invest
Shared address
→
Ceres Pharmaceuticals
Shared address
→
What's Cooking Group
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Registered office

on the map · from the address register
seat.Municipality exact location from the address register
23 companies at this address See who is registered here

Establishment units

1 location
Etixx Sports
Kortrijksesteenweg 1091, 9051 GentVervaardiging van voedingssupplementen en voedingsmiddelen die met vitaminen, proteïnen, enz zijn verrijkt
since 20162.259.405.459
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area1.1 ha
Buildings1
Building footprint3,960 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44062B0301/00D003 Flanders 1.1 ha 1 · 3,960 m² -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

8 acts
Capital history · 2
29-04-2026
Capital: amount: 1087000.0, shares: 2596, currency: EUR
21-12-2018
v3.2
Address history · 1
15-02-2022
v3.2
All acts · 8 updated 3 months ago
2026
29-04-2026 Act object · Notarial deed · General meeting · Statute amendment Open-capture extraction·Kim Van Poucke
  • Filing: 2026-04-27 · MD Pharma
  • Publication: 2026-04-29 · MD Pharma
  • Act object: ONTSLAGEN, BENOEMINGEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), KAPITAAL, AANDELEN · MD Pharma
  • Notarial deed: 2026-03-30 · MD Pharma
  • General meeting: 2026-03-30 · MD Pharma
  • Statute amendment: Wetboek van vennootschappen en verenigingen · MD Pharma
  • Statute amendment: volledig nieuwe statuten · MD Pharma
  • Capital: amount: 1087000.0, shares: 2596, currency: EUR · MD Pharma
  • Annual meeting schedule: eerste vrijdag van de maand juni om negentien (19) uur · MD Pharma
  • Officer resignation: 2026-03-30 · MD CONSULT
  • Officer resignation: 2026-03-30 · AQUITANIA
  • Officer appointment: role: bestuurder, term: 6 jaar · MD CONSULT
  • Officer appointment: role: bestuurder, term: 6 jaar · AQUITANIA
  • Officer appointment: role: gedelegeerd bestuurder · MD CONSULT
  • Mandate compensation: onbezoldigd · MD CONSULT
  • Mandate compensation: onbezoldigd · AQUITANIA
  • Governance rule: MONISTISCH BESTUUR · MD Pharma
  • Power of attorney: coördinatie en neerlegging van de statuten · Kim Van Poucke
  • Power of attorney: administratieve handelingen en formaliteiten · MD CONSULT
  • Power of attorney: administratieve handelingen en formaliteiten · AQUITANIA
  • Power of attorney: administratieve handelingen en formaliteiten · Pieter Vuyge
Summary: Act object · Notarial deed · General meeting · Statute amendmentNotary: Kim Van Poucke
2022
15-02-2022 Registered office moved from Merelbeke to Sint-Denijs-Westrem Registered-office change
  • Lembergsesteenweg 29, 9820 Merelbeke → Kortrijksesteenweg 1091, 9051 Sint-Denijs-Westrem
Summary: v3.2
2021
16-12-2021 Change in the board of directors Director changes
Summary: v3.2
2019
09-05-2019 Anja Imschoot appointed as director Director changes
  • Anja Imschoot, Bestuurder
Summary: v3.2
2018
21-12-2018 Capital increase of €62,000 to €162,000 Capital & shares
  • €100.000 → €162.000
Summary: v3.2
21-12-2018 Articles of association amended Statutes amendment
Summary: v3.2
2017
26-04-2017 2 directors appointed Director changes
  • Mario Debel, Bestuurder
  • Mario Debel, Gedelegeerd bestuurder
Summary: v3.2
2016
20-12-2016 Incorporation of a new NV Incorporation
Summary: oprichting

Analysis

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, nearest first

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht77400Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht77400
Primary activity highlighted.
Names & trade names
Legal nameNL MD Pharma
Registered office
Kortrijksesteenweg 1091 bus B
9051 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.